| 1. |
Wang, J. C. (1996) DNA topoisomerases. Annu. Rev. Biochem.
65, 635–692.
|
| |
| 2. |
Champoux, J. (1990) Mechanistic aspects of type-I topoisomerases, in DNA Topology and Its Biological Effects (Wang, J. C. and Cozarelli, N. R., eds.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 217–242.
|
| |
| 3. |
Gupta, M., Fujimori, A., and Pommier, Y. (1995) Eukaryotic DNA topoisomerases I. Biochim. Biophys. Acta
1262, 1–14.
|
| |
| 4. |
Pommier, Y. (1997) DNA topoisomerase II inhibitors, in Cancer Therapeutics: Experimental and Clinical Agents (Teicher, B. A., ed.), Humana Press, Totowa, NJ, pp. 153–174.
|
| |
| 5. |
Pommier, Y. (1996) Eukaryotic DNA topoisomerase I: genome gatekeeper and its intruders, camptothecins. Semin. Oncol.
23, 3–10.
|
| |
| 6. |
Chen, A. Y. and Liu, L. F. (1994) DNA Topoisomerases: essential enzymes and lethal targets. Annu. Rev. Pharmacol. Toxicol.
94, 194–218.
|
| |
| 7. |
Osheroff, N., Corbett, A. H., Elsea, S. H., and Westergaard, M. (1994) Defining functional drug-interaction domains on topoisomerase
II by exploiting mechanistic differences between drug classes. Cancer Chemother. Pharmacol.
34, 19–25.
|
| |
| 8. |
Bonven, B. J., Gocke, E., and Westergaard, O. (1985) A high affinity topoisomerase I binding sequence is clustered at DNAase
I hypersensitive sites in Tetrahymena R-chromatin. Cell
41, 541–551.
|
| |
| 9. |
Jaxel, C., Capranico, G., Kerrigan, D., Kohn, K. W., and Pommier, Y. (1991) Effect of local DNA sequence on topoisomerase
I cleavage in the presence or absence of camptothecin. J. Biol. Chem.
266, 20418–20423.
|
| |
| 10. |
Leteurtre, F., Fujimori, A., Tanizawa, A., Chhabra, A., Mazumder, A., Kohlhagen, G., Nakano, H., and Pommier, Y. (1994) Saintopin,
a dual inhibitor of DNA topoisomerases I and II, as a probe for drug-enzyme interactions. J. Biol. Chem.
269, 28,702–28,707.
|
| |
| 11. |
Sorensen, B. S., Jensen, P. B., Sehested, M., Jensen, P. S., Kjeldsen, E., Nielsen, O. F., and Alsner, J. (1994) Antagonistic
effect of aclarubicin on camptothecin induced cytotoxicity: role of topoisomerase I. Biochem. Pharmacol.
47, 2105–2110.
|
| |
| 12. |
Hsiang, Y. H., Hertzberg, R., Hecht, S., and Liu, L. F. (1985) Camptothecin induces protein-linked DNA breaks via mammalian
DNA topoisomerase I. J. Biol. Chem.
260, 14,873–14,878.
|
| |
| 13. |
Bigioni, M., Zunino, F., Tinelli, S., Austin, C. A., Willmore, E., and Capranico, G. (1996) Position-specific effects of base
mismatch on mammalian topoisomerase II DNA cleaving activity. Biochemistry
35, 153–159.
|
| |
| 14. |
Freudenreich, C. H. and Kreuzer, K. N. (1994) Localization of an aminoacridine antitumor agent in a type II topoisomerase-DNA
complex. Proc. Natl. Acad. Sci. USA
91, 11,007–11,011.
|
| |
| 15. |
Kingma, P. S. and Osheroff, N. (1997) Apurinic sites are position-specific topoisomerase II poisons. J. Biol. Chem.
272, 1148–1155.
|
| |
| 16. |
Burden, D. A., Kingma, P. S., Froelich-Ammon, S. J., Bjornsti, M.-A., Patchan, M. W., Thompson, R. B., and Osheroff, N. (1996)
Topoisomerase II-etoposide interaction direct the formation of drug-induced enzyme-DNA cleavage complexes. J. Biol. Chem.
271, 29,238–29,244.
|
| |
| 17. |
Pommier, Y., Orr, A., Kohn, K. W., and Riou, J. F. (1992) Differential effects of amsacrine and epipodophyllotoxins on topoisomerase
II cleavage in the human c-myc proto-oncogene. Cancer Res.
52, 3125–3130.
|
| |
| 18. |
Nelson, E. M., Tewey, K. M., and Liu, L. F. (1984) Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase
II on DNA by 4′-(9-acridinylamino)-methanesulfon-m-anisidide. Proc. Natl. Acad. Sci. USA
81, 1361–1365.
|
| |
| 19. |
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning; A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
|
| |
| 20. |
Maxam, A. and Gilbert, W. (1980) Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol.
65, 499–560.
|
| |
| 21. |
Jaxel, C., Kohn, K. W., Wani, M. C., Wall, M. E., and Pommier, Y. (1989) Structure-activity study of the actions of camptothecin
derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor activity. Cancer Res.
49, 1465–1469.
|
| |